{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T11:42:05Z","timestamp":1792755725433,"version":"4.5.0"},"reference-count":21,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T00:00:00Z","timestamp":1753833600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Globally, there are approximately 1\u00b75 million children (0\u201314\u202fyears old) living with human immunodeficiency virus\/acquired immunodeficiency syndrome (HIV\/AIDS), of which 90% are in sub-Saharan Africa. South Africa has the most extensive pediatric HIV care and treatment program. Statistical data from 2023 demonstrated that 152,984 South African children (&amp;lt;15\u202fyears) were living with HIV. Despite the remarkable progress toward achieving the UNAIDS 95-95-95 targets in South African adults, the progress in the pediatric population seems to be lagging. HIV\/AIDS remains a major factor in the morbidity and mortality of children. Some of the challenges impacting successful treatment outcomes include a high rate of loss to follow-up, virological non-suppression, and difficulties with treatment adherence as the children are reaching adulthood, indicating an urgent need for improved quality of care for children on antiretroviral therapy. The occurrence of adverse drug reactions (ADRs) is one of the problems affecting patient retention in treatment and is associated with an increased risk of incomplete viral suppression. To address these issues, strengthening spontaneous ADR reporting among HIV-infected pediatric patients at healthcare facilities has contributed to developing strategies for the prediction, identification, reporting, and prevention of ADR occurrence. In addition, establishing the ARV-Pediatric Registry has improved the quality of care for children on ART by enabling timely interventions and monitoring the effectiveness and safety of ART. These initiatives will help to address the specific challenges associated with reaching the 95-95-95 targets and provide a pathway forward for sustainable healthcare delivery for this vulnerable population.<\/jats:p>","DOI":"10.3389\/fpubh.2025.1623386","type":"journal-article","created":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T05:28:38Z","timestamp":1753853318000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishment of antiretroviral pediatric registry: efforts toward achieving the UNAIDS 95-95-95 targets in the Free State Province, South Africa"],"prefix":"10.3389","volume":"13","author":[{"given":"Bukola R.","family":"Omotoso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mukesh","family":"Dheda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph B.","family":"Sempa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Tabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Refuoe","family":"Baleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tshepang","family":"Jiane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thabiso R.","family":"Mofokeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,30]]},"reference":[{"key":"ref1","first-page":"2023","volume-title":"The path that ends AIDS: UNAIDS Global AIDS update 2024","year":""},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e25780","DOI":"10.1002\/jia2.25780","article-title":"Global HIV mortality trends among children on antiretroviral treatment corrected for under-reported deaths: an updated analysis of the international epidemiology databases to evaluate AIDS collaboration","volume":"24","author":"Kassanjee","year":"2021","journal-title":"J Int AIDS Soc"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"100435","DOI":"10.1016\/j.ijregi.2024.100435","article-title":"Trends in continuity of treatment among children and adolescents living with HIV in 14 districts in South Africa from 2018-2023: a retrospective program analysis","volume":"13","author":"Mugisa","year":"2024","journal-title":"IJID Regions"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13052-024-01706-w","article-title":"Treatment failure among sub-Sahara African children living with HIV: a systematic review and meta-analysis","volume":"50","author":"Walle","year":"2024","journal-title":"Ital J Pediatr"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s12098-021-04045-4","article-title":"Short-term adverse drug reactions to antiretroviral therapy in children with HIV: a cohort study","volume":"90","author":"Ray","year":"2023","journal-title":"Indian J Pediatr"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"146","DOI":"10.21106\/ijma.471","article-title":"Clinical characteristics of children with HIV initiated on antiretroviral treatment at HIV clinics in Bloemfontein, South Africa","volume":"10","author":"Walubo","year":"2021","journal-title":"Int J Mater Child Health AIDS"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2165\/00002018-200326050-00001","article-title":"Application of quantitative signal detection in the Dutch spontaneous reporting system for adverse drug reactions","volume":"26","author":"Van Puijenbroek","year":"2003","journal-title":"Drug Saf"},{"key":"ref8","volume-title":"National consolidated guidelines for the management of HIV in adults, adolescents, children and infants and prevention of mother-to-child transmission","year":"2020"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e332","DOI":"10.1016\/S2352-3018(22)00044-3","article-title":"Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1\u20132 trial","volume":"9","author":"Ruel","year":"2022","journal-title":"Lancet HIV"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"52","DOI":"10.9734\/JSRR\/2020\/v26i230224","article-title":"Dolutegravir (DTG) based fixed dose combination (FDC) of Tenofovir\/lamivudine\/Dolutegravir (TLD) and viral load suppression in children in Port Harcourt, Nigeria","volume":"26","author":"Paul","year":"2020","journal-title":"J Sci Res Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/S2352-4642(23)00164-5","article-title":"Neuropsychiatric manifestations and sleep disturbances with dolutegravir-based antiretroviral therapy versus standard of care in children and adolescents: a secondary analysis of the ODYSSEY trial","volume":"7","author":"Turkova","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"a1458","DOI":"10.4102\/sajhivmed.v24i1.1458","article-title":"Breaking the unbreakable: a paediatric case of dolutegravir resistance from KwaZulu-Natal","volume":"24","author":"Malinga","year":"2023","journal-title":"South Afr J HIV Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1186\/s12889-024-20013-x","article-title":"The viral load monitoring cascade in HIV treatment programmes in sub-Saharan Africa: a systematic review","volume":"24","author":"Kippen","year":"2024","journal-title":"BMC Public Health"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"e766","DOI":"10.1016\/S2352-3018(21)00265-4","article-title":"Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries","volume":"8","author":"Han","year":"2021","journal-title":"Lancet HIV"},{"key":"ref15","volume-title":"South Africa launches 1.1 million HIV campaign to close treatment gap","year":"2025"},{"key":"ref16","first-page":"1","article-title":"A retrospective pharmacovigilance study of antiretroviral therapy in a pediatric setting in Benin","volume":"113","author":"Allabi","year":"","journal-title":"J Pharmacovigil Pharm Ther"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/2325958218823208","article-title":"Prevalence of adverse drug reactions among pediatric patients on antiretroviral therapy in selected hospitals in eastern Ethiopia: 8-year retrospective cross-sectional study","volume":"18","author":"Abdela","year":"2019","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5863\/1551-6776-28.3.197","article-title":"Adverse drug reactions to antiretroviral therapy: frequency, type, and risk factors in children in Mali","volume":"28","author":"Oumar","year":"2023","journal-title":"J Pediatr Pharmacol Ther"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e273","DOI":"10.1016\/S2352-3018(24)00312-6","article-title":"Pharmacokinetics and safety of dolutegravir in children receiving rifampicin tuberculosis treatment in South Africa (ORCHID): a prospective cohort study","volume":"12","author":"Naidoo","year":"2025","journal-title":"Lancet HIV"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"e433","DOI":"10.1016\/S2352-3018(23)00081-4","article-title":"Standard-dose versus double-dose dolutegravir in HIV-associated tuberculosis in South Africa (RADIANT-TB): a phase 2, non-comparative, randomised controlled trial","volume":"10","author":"Griesel","year":"2023","journal-title":"Lancet HIV"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"e0304239","DOI":"10.1371\/journal.pone.0304239","article-title":"Incidence of lost to follow up among HIV-positive children on antiretroviral therapy in Ethiopia: systematic review and meta-analysis","volume":"19","author":"Girma","year":"2024","journal-title":"PLoS One"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1623386\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T05:28:39Z","timestamp":1753853319000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2025.1623386\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,30]]},"references-count":21,"alternative-id":["10.3389\/fpubh.2025.1623386"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2025.1623386","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,30]]},"article-number":"1623386"}}